Company profile
Aptadir Therapeutics
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.
- Location
- Milan, Lombardia, Italy, Europe
- Website
- aptadir.com
Latest known funding
Seed round
- Capital
- $45.5M
- Announced
- Sep 29, 2026